ArticleAndrologia2020

Low reduction of prostate volume is a significant predictor of prostate cancer at subsequent biopsy in patients with dutasteride: A retrospective study.

Daisuke Obinata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.